BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 545300)

  • 1. [Antimicrobial therapy in granulopenic patients with malignant hematologic diseases (author's transl)].
    Klastersky J
    Nouv Rev Fr Hematol (1978); 1979; Suppl():XIX-XXI. PubMed ID: 545300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bacterial sepsis in the hematologic neutropenic patient].
    Todeschini G; Benato G; Carlini S; Veneri D
    Haematologica; 1989 Oct; 74(5 Suppl):297-309. PubMed ID: 2480272
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of synergistic combinations of antibiotics in patients with haematological diseases.
    Klastersky J
    Clin Haematol; 1976 Jun; 5(2):361-77. PubMed ID: 780029
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibacterial therapy--special considerations in neutropenic patients.
    Rodriguez V; Bodey GP
    Clin Haematol; 1976 Jun; 5(2):347-60. PubMed ID: 181192
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
    Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
    Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
    [No Abstract]   [Full Text] [Related]  

  • 7. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of different measures of outcome on the results of studies of empiric antibiotic therapy in febrile neutropenic patients.
    Elliott CR; Pater JL
    Clin Invest Med; 1988 Oct; 11(5):327-30. PubMed ID: 3141096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A; Bucaneve G
    Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of empirical antibiotic therapy in febrile neutropenic patients.
    Barnes RA; Rogers TR
    Br J Haematol; 1987 May; 66(1):137-40. PubMed ID: 3593650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
    Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory support for choosing and monitoring antimicrobial therapy in severely ill patients.
    Zinner SH; Blaser J; Gaya H
    Am J Med; 1986 May; 80(5C):59-63. PubMed ID: 3717189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
    Parr MD; Waite WW; Hansen LA; McDaniel PA
    Am J Hosp Pharm; 1985 Nov; 42(11):2484-8. PubMed ID: 4073066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience of therapy for sepsis in cancer patients with neutropenia].
    Smirnova AE; Lileev DV
    Anesteziol Reanimatol; 2005; (5):66-7. PubMed ID: 16318058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of infections in cancer patients: a review.
    Sim SK
    Am J Hosp Pharm; 1975 Jan; 32(1):35-44. PubMed ID: 1092159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Granulocytopenia in oncohematology].
    Mandelli F; Avvisati G; Fenu S; Venditti M; Martino P
    Ann Ist Super Sanita; 1987; 23(4):727-30. PubMed ID: 3452282
    [No Abstract]   [Full Text] [Related]  

  • 20. Monotherapy versus dual therapy based on risk categorization of febrile neutropenic patients.
    Ohyashiki K
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S56-8. PubMed ID: 15250023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.